Atom Investors’s Artivion AORT Stock Holding History

Atom Investors’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,076	Closed	-$399K	–	507
2018 Q4	$399K	Buy	+14,076	New	+$423K	0.04%	449

Other funds holding AORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Atom Investors's AORT Position: Q1 2019 in Review

Atom Investors sold out of Artivion (AORT) in Q1 2019, closing a stake of 14,076 shares — an estimated $399K sold.

Atom Investors first reported a position in AORT in Q4 2018 and held it in 1 quarter. The position peaked at $399K in Q4 2018. 144 funds tracked by Wall St. Rank hold AORT as of Q1 2019.

Atom Investors reported no remaining Artivion position as of Q1 2019 after selling out during the quarter.
Atom Investors sold 14,076 Artivion shares in Q1 2019, an estimated $399K.
Atom Investors first reported a position in Artivion in Q4 2018 and held it in 1 quarter.
Atom Investors's Artivion position peaked at $399K in Q4 2018.
144 funds tracked by Wall St. Rank held Artivion as of Q1 2019.

Based on Atom Investors's 13F filing for Q1 2019, filed 15 May 2019.